Surrozen Pauses Early-Stage Ulcerative Colitis Study Due To Liver Associated Adverse Events
Tucked in its Q3 earnings release on Monday afternoon, Surrozen Inc (NASDAQ:SRZN) voluntarily paused enrollment in the single ascending dose (SAD) portion…